KevinPBartonMD
Hematology • Maywood, ILProfessor of Medicine, Loyola University of Chi Stritch School of Medicine
Dr. Barton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2160 S 1st Ave
# Luh
Maywood, IL 60153Phone+1 708-216-3304Fax+1 708-216-1259
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1989 - 1994- University of ChicagoResidency, Internal Medicine, 1986 - 1989
Ohio State University College of MedicineClass of 1986
Certifications & Licensure
IL State Medical License 1989 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma Start of enrollment: 2009 Jan 01
Publications & Presentations
PubMed
- National Trends and Factors Associated with Voluntary Refusal of Glioblastoma Treatment: A Retrospective Review of the National Cancer Database.Oleksandr Strelko, James Swanson, Parker Woldt, Joseph Frazzetta, Joshua Simon
World Neurosurgery. 2024-09-01 - Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma.Erik E Rabin, Jonathan Huang, Miri Kim, Andreas Mozny, Kristen L Lauing
Brain, Behavior, & Immunity - Health. 2024-07-01 - 2 citationsCaspase 8 deletion causes infection/inflammation-induced bone marrow failure and MDS-like disease in mice.Shanhui Liu, Kanak Joshi, Lei Zhang, Wenyan Li, Ryan Mack
Cell Death & Disease. 2024-04-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
